On May 11, Hisense Ultrasound signed a bulk order with Indonesian professional medical equipment agents, officially announcing its entry into the Indonesian market. It is reported that this is also a new breakthrough in the Southeast Asian market after Hisense Ultrasound won the first overseas order in the South African market in April, indicating that domestic high-end medical equipment represented by Hisense Ultrasound HD60 has been accepted by more and more overseas markets. .
Indonesia is the largest economy in Southeast Asia with a population of 270 million. In recent years, especially after the outbreak of the epidemic, the local government has continued to increase investment in the healthcare industry, upgrade medical facilities to improve the level of medical services, and the medical market has great potential for development. Since last year, Hisense HD60 color ultrasound products have entered a well-known local hospital in Jakarta, the capital of Indonesia, to carry out product clinical trials.
“The image effect is very good. The ergonomic design is very user-friendly and easy to operate. The first time I used this ultrasound, I got a good experience. The product is suitable for a variety of clinical applications and has many more High-end functions are indeed a good product with high cost performance.” Dr. Spride, a local hospital expert, said after the clinical trial.
It is understood that Hisense HD60 color ultrasound products cover 3,000 functions and 1,200 measurement items, and adopt the world’s leading architecture platform based on GPU extreme-speed parallel processing. Accurate and excellent image quality, industry-leading image intelligence, and user-friendly operation experience.
The person in charge of Hisense Medical said that since the beginning of this year, Hisense Medical has further increased its overseas market, and the latest medical achievements of Hisense ultrasound and 55-inch medical endoscopy professional display It has successively appeared in overseas exhibitions such as CES in the United States, Arab Health in Dubai, HOSPEX in Indonesia, RCRT in Thailand, and Social & Healthcare in Finland, and has received extensive attention. In 2022, B2B industry going overseas has become an important strategic development direction of Hisense Group. Hisense will also continue to increase the layout of products such as ultrasound and medical display in overseas markets, and continue to expand its overseas footprint.